NDAORALFOR SUSPENSION
Approved
Aug 2022
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the gastric mucosa, omeprazole has…
Loss of Exclusivity
LOE Date
Mar 1, 2040
170 months away
Patent Expiry
Mar 1, 2040
Company
R-Pharm US
NJ - Princeton